Atlas Trials

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

Clinical trial NCT03038178 · COMPLETED

Trial details

NCT number
NCT03038178
Sponsor
Kevin Winthrop
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mycobacterium Infections, NontuberculousMycobacteria, Atypical
Start date
2016-10-01
Primary completion
2019-10-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.